Biotronik AG — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium ScaffoldThe study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.	Maladie coronarienne	Non applicable	À vérifier	Germany, Hungary, Italy, Latvia, Poland, Spain, Switzerland	À vérifier
Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium ScaffoldThe study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.	Maladie coronarienne	Non applicable	À vérifier	Germany, Hungary, Italy, Latvia, Poland, Spain, Switzerland	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold	Maladie coronarienne	Non applicable	NCT07091682	BIOMAG-LL — Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions	ACTIVE_NOT_RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.